Detailed price information for Shattuck Labs Inc (STTK-Q) from The Globe and Mail including charting and trades.
Detailed price information for Shattuck Labs Inc (STTK-Q) from The Globe and Mail including charting and trades.
Detailed price information for Arcus Biosciences Inc (RCUS-N) from The Globe and Mail including charting and trades.
Detailed price information for Atricure Inc (ATRC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Shattuck Labs Inc (STTK-Q) from The Globe and Mail including charting and trades.
Shattuck Labs pivots to immunology, focusing on DR3-targeted therapies for IBD, notably SL-325, after discontinuing oncology. Read why STTK stock is a buy.
Two analysts weighed in with new takes on the biotech.
Shattuck Labs (STTK) has an average rating of buy and mean price target of $15, according to analyst
This is the newest page. Registered accounts read further back.